Advertisement

Citations to this article

Abstract

We have shown previously that a group IIA phospholipase A2 (PLA2) is responsible for the potent bactericidal activity of inflammatory fluids against many Gram-positive bacteria. To exert its antibacterial activity, this PLA2 must first bind and traverse the bacterial cell wall to produce the extensive degradation of membrane phospholipids (PL) required for bacterial killing. In this study, we have examined the properties of the cell-wall that may determine the potency of group IIA PLA2 action. Inhibition of bacterial growth by nutrient deprivation or a bacteriostatic antibiotic reversibly increased bacterial resistance to PLA2-triggered PL degradation and killing. Conversely, pretreatment of Staphylococcus aureus or Enterococcus faecium with subinhibitory doses of β-lactam antibiotics increased the rate and extent of PL degradation and/or bacterial killing after addition of PLA2. Isogenic wild-type (lyt+) and autolysis-deficient (lyt–) strains of S. aureus were equally sensitive to the phospholipolytic action of PLA2, but killing and lysis was much greater in the lyt+ strain. Thus, changes in cell-wall cross-linking and/or autolytic activity can modulate PLA2 action either by affecting enzyme access to membrane PL or by the coupling of massive PL degradation to autolysin-dependent killing and bacterial lysis or both. Taken together, these findings suggest that the bacterial envelope sites engaged in cell growth may represent preferential sites for the action and cytotoxic consequences of group IIA PLA2 attack against Gram-positive bacteria.

Authors

Amy K. Foreman-Wykert, Yvette Weinrauch, Peter Elsbach, Jerrold Weiss

×

Total citations by year

Year: 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 Total
Citations: 2 1 3 8 3 1 2 1 1 2 2 1 2 3 2 3 37
Citation information

Citations to this article (37)

Title and authors Publication Year
Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease
JF Pierre, AJ Barlow-Anacker, CS Erickson, AF Heneghan, GE Leverson, SE Dowd, ML Epstein, KA Kudsk, A Gosain
Journal of Pediatric Surgery 2014
IL-25 Improves Luminal Innate Immunity and Barrier Function During Parenteral Nutrition:
AF Heneghan, JF Pierre, A Gosain, KA Kudsk
Annals of Surgery 2014
Antibacterial properties of recombinant human non-pancreatic secretory phospholipase A2
S Qiu, L Lai
Biochemical and Biophysical Research Communications 2013
Antibacterial Properties of Intestinal Phospholipase A2 from the Common Stingray Dasyatis pastinaca
AB Bacha, I Abid, H Horchani
Applied Biochemistry and Biotechnology 2012
Lactoferrin: an alternative view of its role in human biological fluids<sup>1</sup><sup>1</sup> This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal's usual peer review process
DB Alexander, M Iigo, K Yamauchi, M Suzui, H Tsuda
Biochemistry and Cell Biology 2012
Role of plasma bactericidal/permeability-increasing protein, group IIA phospholipase A 2 , C-reactive protein, and white blood cell count in the early detection of severe sepsis in the emergency department
R Uusitalo-Seppälä, H Peuravuori, P Koskinen, T Vahlberg, EM Rintala
Scandinavian Journal of Infectious Diseases 2012
Route and Type of Nutrition and Surgical Stress Influence Secretory Phospholipase A2 (sPLA2) Secretion of the Murine Small Intestine
JF Pierre, AF Heneghan, FH Tsao, Y Sano, MA Jonker, J Omata, J Lan, KA Kudsk
JPEN. Journal of parenteral and enteral nutrition 2011
Antibacterial properties of chicken intestinal phospholipase A2
A Karray, YB Ali, Y Gargouri, S Bezzine
Lipids in Health and Disease 2011
Characterization of Staphylococcus aureus Cardiolipin Synthases 1 and 2 and Their Contribution to Accumulation of Cardiolipin in Stationary Phase and within Phagocytes▿
T Koprivnjak, D Zhang, CM Ernst, A Peschel, WM Nauseef, JP Weiss
Journal of bacteriology 2011
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
EA Dennis, J Cao, YH Hsu, V Magrioti, G Kokotos
Chemical Reviews 2011
Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins
LY Low, C Yang, M Perego, A Osterman, R Liddington
The Journal of biological chemistry 2011
Bacterial resistance mechanisms against host defense peptides
T Koprivnjak, A Peschel
Cellular and Molecular Life Sciences 2011
Genes That Link Nephritis to Autoantibodies and Innate Immunity
M Segelmark
New England Journal of Medicine 2011
Genetics of kidney failure and the evolving story of APOL1
DJ Friedman, MR Pollak
Journal of Clinical Investigation 2011
A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis
E Boilard, Y Lai, K Larabee, B Balestrieri, F Ghomashchi, D Fujioka, R Gobezie, JS Coblyn, ME Weinblatt, EM Massarotti, TS Thornhill, M Divangahi, H Remold, G Lambeau, MH Gelb, JP Arm, DM Lee
EMBO Molecular Medicine 2010
Catalytic and non-catalytic functions of human IIA phospholipase A2
CN Birts, CH Barton, DC Wilton
Trends in Biochemical Sciences 2010
Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice
M Murakami, Y Taketomi, C Girard, K Yamamoto, G Lambeau
Biochimie 2010
NETs: a new strategy for using old weapons
V Papayannopoulos, A Zychlinsky
Trends in Immunology 2009
Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3
T Koprivnjak, C Weidenmaier, A Peschel, JP Weiss
Infection and immunity 2008
The effects of bee (Apis mellifera) venom phospholipase A2 on Trypanosoma brucei brucei and enterobacteria
MC Boutrin, HA Foster, VW Pentreath
Experimental Parasitology 2008
How human neutrophils kill and degrade microbes: an integrated view
WM Nauseef
Immunological Reviews 2007
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
M Menschikowski, A Hagelgans, G Siegert
Prostaglandins & Other Lipid Mediators 2006
Roles of Group IIA Phospholipase A2 and Complement in Killing of Bacteria by Acute Phase Serum
JO Gronroos, JH Salonen, M Viander, TJ Nevalainen, VJ Laine
Scandinavian Journal of Immunology 2005
BLOOD NEUTROPHIL BACTERICIDAL ACTIVITY AGAINST METHICILLIN-RESISTANT AND METHICILLIN-SENSITIVE STAPHYLOCOCCUS AUREUS DURING CARDIAC SURGERY
A Mekontso-Dessap, S Honor??, M Kirsch, A Plonquet, E Fernandez, L Touqui, JP Farcet, CJ Soussy, D Loisance, C Delclaux
Shock 2005
Fosfolipasas A2 segregadas (sPLA2):¿amigas o enemigas? ¿Actores de la resistencia antibacteriana y antivirus de la inmunodeficiencia humana?
VG Villarrubia, LA Costa, RA Díez
Medicina Clínica 2004

Advertisement
Advertisement